Benzinga | Jun 28, 2021 06:12AM EDT

HC Wainwright & Co. Maintains Buy on Anavex Life Sciences, Raises Price Target to $39

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and raises the price target from $25 to $39.